NCT03478345

Brief Summary

There have been some preliminary studies, primarily in animals, that suggest that exposure to some of the chemicals in our everyday environment, such as the chemicals found in plastics, may cause weight gain. It is not clear whether this also happens in humans, or whether decreasing exposure to these chemicals can improve success with weight loss when people adopt healthy lifestyle changes. The THRIVE Study is a 4-week group healthy lifestyle education program that is designed to determine whether:

  • changes in dietary habits and the types of personal care products used can decrease a person's exposure to chemicals in our environment that have been suggested to cause weight gain
  • whether any measurable changes in body composition (fat tissue vs. lean tissue) can be seen as a result of participating in the healthy lifestyle program.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 13, 2018

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

March 20, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 27, 2018

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2018

Completed
Last Updated

February 15, 2019

Status Verified

February 1, 2019

Enrollment Period

10 months

First QC Date

March 20, 2018

Last Update Submit

February 12, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • Changes in urinary endocrine disrupting chemical levels (especially phthalates)

    Difference between urinary endocrine disrupting chemical levels from urine collected at the baseline study visit and urine collected at the final study visit.

    Six weeks

  • Changes in body composition (weight and visceral adipose tissue volume)

    Difference between body weight and visceral adipose tissue volume (measured by dual x-ray absorptiometry) from baseline to final study visit.

    Six weeks

Secondary Outcomes (1)

  • Correlation between dietary patterns and urinary endocrine disrupting chemical levels

    baseline

Study Arms (1)

THRIVE Study

EXPERIMENTAL
Behavioral: endocrine disruptor chemical reduction intervention

Interventions

Participants will take part in a 4-week intervention consisting of a modified (shortened) version of the Diabetes Prevention Program diet and physical activity group education program, with instructions to reduce endocrine disruptor chemical exposure through changes in food handling and personal care products.

THRIVE Study

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsBecause of potential hormonal influences on body composition, eligibility criteria for this study requires being biologically female.
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • female
  • BMI \>25 kg/m2
  • willingness to participate in the 4-week long study
  • English speaking
  • capable of giving informed consent.

You may not qualify if:

  • males
  • current smoker, or having quit smoking within the past 6 months
  • currently or recently (past 6 months) pregnant or lactating, or planning to become pregnant in the next year
  • engaging in \>150 minutes exercise/week
  • weight loss of ≥5 pounds over the past 6 months
  • post-menopausal
  • pre-existing chronic diseases
  • use of medications known to alter body composition such as hormone replacements, oral contraceptives, and steroids
  • homeless persons, or individuals who have active drug/alcohol dependence or abuse history
  • Non-English speaking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Milken Institute School of Public Health, George Washington University

Washington D.C., District of Columbia, 20052, United States

Location

MeSH Terms

Conditions

OverweightObesity

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Kim Robien, PhD, RD

    Department of Exercise and Nutrition Sciences, Milken Institute School of Public Health, George Washington University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 20, 2018

First Posted

March 27, 2018

Study Start

March 13, 2018

Primary Completion

December 31, 2018

Study Completion

December 31, 2018

Last Updated

February 15, 2019

Record last verified: 2019-02

Data Sharing

IPD Sharing
Will not share

Will not share data until study is complete and all data deidentified

Locations